Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence

Affiliations

¹ 1 Harrington Heart & Vascular Institute, University Hospitals, Cleveland, OH, USA.
² 2 Ochsner Medical Center, New Orleans, LA, USA.
³ 3 Vanderbilt University Medical Center, Nashville, TN, USA.
⁴ 4 Mayo Clinic, Rochester, MN, USA.
⁵ 5 Kaiser Permanente Hospital, Honolulu, HI, USA.
⁶ 6 Mount Sinai Health System, New York, NY, USA.
⁷ 7 Palmetto Health USC Medical Group, Columbia, SC, USA.
⁸ 8 Duke University and Duke Clinical Research Institute, Durham, NC, USA.
⁹ 9 Massachusetts General Hospital, Boston, MA, USA.
¹⁰ 10 Miami Cardiac & Vascular Institute, Miami, FL, USA.
¹¹ 11 Baptist Cardiac & Vascular Institute, Miami, FL, USA.
¹² 12 Newton-Wellesley Hospital, Newton, MA, USA.

Editorial

Mehdi H Shishehbor et al. Vasc Med. 2018 Dec.

. 2018 Dec;23(6):558-559.

doi: 10.1177/1358863X18802969. Epub 2018 Sep 21.

¹ 1 Harrington Heart & Vascular Institute, University Hospitals, Cleveland, OH, USA.
² 2 Ochsner Medical Center, New Orleans, LA, USA.
³ 3 Vanderbilt University Medical Center, Nashville, TN, USA.
⁴ 4 Mayo Clinic, Rochester, MN, USA.
⁵ 5 Kaiser Permanente Hospital, Honolulu, HI, USA.
⁶ 6 Mount Sinai Health System, New York, NY, USA.
⁷ 7 Palmetto Health USC Medical Group, Columbia, SC, USA.
⁸ 8 Duke University and Duke Clinical Research Institute, Durham, NC, USA.
⁹ 9 Massachusetts General Hospital, Boston, MA, USA.
¹⁰ 10 Miami Cardiac & Vascular Institute, Miami, FL, USA.
¹¹ 11 Baptist Cardiac & Vascular Institute, Miami, FL, USA.
¹² 12 Newton-Wellesley Hospital, Newton, MA, USA.

No abstract available

Publication types